Please assess the completion status of the following clinical trial:

Trial Title: Amoxicillin Bioequivalence Study Brazil - Fast

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 18 and 50 years~* Body mass index between 18,5 and 25,0, can vary up to 15% for the upper limit (18,5 and 28,75)~* Good health conditions~* Obtain signed informed consent~Exclusion Criteria:~* Results of laboratory tests outside the normal limits, unless they are considered clinically irrelevant~* The volunteers who underwent surgery or who were hospitalized for any reason before the start of the study will be reviewed by the physician on admission in the study, observing a period of exclusion of 4 to 8 weeks~* Positive test for hepatitis B, hepatitis C or HIV in pre study evaluation~* Known hypersensitivity to the study drug or to compounds chemically related~* Use of experimental drug or participation in any clinical study within 6 months prior to study initiation~* Use of regular medication within 2 weeks prior to study initiation~* History of alcohol or drugs abuse or intake of alcohol within 24 hours prior to the period of confinement~* Consume of inductive drugs and/or enzymatic inhibitors (CYP450 - hepatic), that are toxic for the organism or presenting long half-life's elimination within 30 days prior to study initiation~* Use of MAO and serotonin reuptake inhibitors within 2 weeks prior to study initiation~* Volunteers with psychiatric or psychological illness unless they are considered clinically irrelevant by the investigator~* History or presence of hepatic, renal or gastrointestinal illness or other condition that interferes on drug's absorption, distribution, excretion or metabolism~* History of neurological, endocrine, pulmonary, hematologic, immune, brain, metabolic or cardiovascular illness~* Hypo or hypertension of any etiologic that needs pharmacologic treatment~* History or clinical case of myocardial infarction, angina and/or heart failure~* The volunteer donated or lost 450 mL or more of blood within the 3 months prior to the study initiation~* The volunteer has any condition that obstructs his/her participation in the study according the investigator's judgement~* Smoking~* Positive beta HCG exam for women~* Breastfeeding women~* Women making use of contraceptive medication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Test formulation (Type: ACTIVE_COMPARATOR): Test product: Amoxicillin powder for oral suspension (Clamoxyl®) 500mg/5mL in Period 1; followed by 14-days washout period during which no medication was administered; followed by reference product: Amoxil® 500mg/5mL in Period 2.
- Reference formulation (Type: ACTIVE_COMPARATOR): Reference product: Amoxil® 500mg/5mL powder for oral suspension in Period 1; followed by 14-days washout period during which no medication was administered; followed by test product: Amoxicillin powder for oral suspension (Clamoxyl®) 500mg/5mL in Period 2

Based on this trial design, predict the completion outcome and termination type (if applicable).